• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】21431

【品名】methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate

【CA登记号】1080-06-4

【 分 子 式 】C10H13NO3

【 分 子 量 】195.21816

【元素组成】C 61.53% H 6.71% N 7.17% O 24.59%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(XXIII)

Tyrosine methyl ester (XXIII) was acylated with butanesulfonyl chloride (XIV) in the presence of pyridine to produce sulfonamide (XXIV). Mitsunobu coupling of pyridinyl butanol (XX) with the phenolic compound (XXIV) furnished ether (XXV). Subsequent hydrolysis of the methyl ester group of (XXV) employing LiOH afforded acid (XXVI). The title piperidine compound was then obtained by catalytic hydrogenation of the pyridine ring of (XXVI) in the presence of Pd/C.

1 Chung, J.Y.L.; Zhao, D.; Hughes, D.L. (Merck & Co., Inc.); Process for preparing fibrinogen receptor antagonists. US 5312923; WO 9316994 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XIV) 26779 1-butanesulfonyl chloride 2386-60-9 C4H9ClO2S 详情 详情
(XX) 59550 4-(4-pyridinyl)-1-butanol C9H13NO 详情 详情
(XXIII) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(XXIV) 59552 methyl (2S)-2-[(butylsulfonyl)amino]-3-(4-hydroxyphenyl)propanoate C14H21NO5S 详情 详情
(XXV) 59553 methyl (2S)-2-[(butylsulfonyl)amino]-3-{4-[4-(4-pyridinyl)butoxy]phenyl}propanoate C23H32N2O5S 详情 详情
(XXVI) 59554 (2S)-2-[(butylsulfonyl)amino]-3-{4-[4-(4-pyridinyl)butoxy]phenyl}propanoic acid C22H30N2O5S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The reaction of L-tyrosine methyl ester (I) with ethyl chloroformate and K2CO3 in water gives the carbamate (II), which is protected with Bn-Br and K2CO3 in DMF, yielding the benzyl ether (III). The reduction of (III) by means of LiAlH4 in refluxing THF affords the chiral 2-methylaminopropanol (IV), which is protected as its Boc derivative (V) by means of Boc2O. The oxidation of (V) by means of DMP provides the carbaldehyde (VI), which is reductocondensed with glycine methyl ester (VII) by means of NaBH3CN in methanol to give the adduct (VIII). Elimination of the Boc protecting group of (VIII) by means of TFA yields the diamine (IX), which is cyclized by means of NH4OH in ethanol to afford the piperazinone (X). Elimination of the benzyl protecting group of (X) by hydrogenation with H2 over Pd/C provides the phenol (XIa)-(XIb), which is cyclized by means of bis(acetoxy)iodobenzene in hexafluoroisopropanol to give the spiranic cyclohexadienone (XII). The hydrogenation of (XII) by means of Tes-H and CuI in dichloromethane yields the spiranic cyclohexanone (XIII), which is finally ketalized by means of ethyleneglycol (XIV) and PPTS in refluxing benzene to provide the target ethyleneketal intermediate (XV) (See scheme no. 18599903a, intermediate (XV)).

1 Mizutani, H.; et al.; Facile synthesis of enantiopure (-)-TAN1251A. Tetrahedron Lett 2002, 43, 13, 2411.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(II) 57099 methyl (2S)-2-[(ethoxycarbonyl)amino]-3-(4-hydroxyphenyl)propanoate C13H17NO5 详情 详情
(III) 57100 methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[(ethoxycarbonyl)amino]propanoate C20H23NO5 详情 详情
(IV) 57101 (2S)-3-[4-(benzyloxy)phenyl]-2-(methylamino)-1-propanol C17H21NO2 详情 详情
(V) 57102 tert-butyl (1S)-1-[4-(benzyloxy)benzyl]-2-hydroxyethyl(methyl)carbamate C22H29NO4 详情 详情
(VI) 57103 tert-butyl (1S)-1-[4-(benzyloxy)benzyl]-2-oxoethyl(methyl)carbamate C22H27NO4 详情 详情
(VII) 17568 methyl 2-aminoacetate C3H7NO2 详情 详情
(VIII) 57104 methyl 2-({(2S)-3-[4-(benzyloxy)phenyl]-2-[(tert-butoxycarbonyl)(methyl)amino]propyl}amino)acetate C25H34N2O5 详情 详情
(IX) 57105 methyl 2-{[(2S)-3-[4-(benzyloxy)phenyl]-2-(methylamino)propyl]amino}acetate C20H26N2O3 详情 详情
(X) 57106 (6S)-6-[4-(benzyloxy)benzyl]-1-methyl-2-piperazinone C19H22N2O2 详情 详情
(XI) 57107 (6S)-6-(4-hydroxybenzyl)-1-methyl-2-piperazinone C12H16N2O2 详情 详情
(XII) 57108   C12H14N2O2 详情 详情
(XIII) 57109   C12H18N2O2 详情 详情
(XIV) 11295 Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol 107-21-1 C2H6O2 详情 详情
(XV) 48806   C14H22N2O3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

Racemic cyclohexylphenyl glycolic acid (CHPGA) (I) is dissolved with (L)-tyrosine methyl ester (II) in refluxing acetonitrile/water to yield a mixture of diastereomeric salts, which is resolved by crystallization to afford the desired diastereomeric salt [(S)-CHPGA-(L)-TME] (III). Finally, the hydrolysis of salt (III) with HCl or H2SO4 at 40-50ºC in toluene yields the enantiomer (IV). Alternatively intermediate (IV) can be obtained as follows: acetalization of (S)-mandelic acid (V) with pivaldehyde (VI) in pentane and catalytic TfOH provides derivative (VII), which is then treated with LHMDS and then condensed with cyclohexanone (VIII) in THF to furnish aldol adduct (IX). Elimination of tertiary alcohol in (IX) with SOCl2 and pyridine in THF gives derivative (X), which is then converted into intermediate (IV) either by first hydrolysis of lactone (X) with KOH in MeOH and subsequent hydrogenation of the obtained derivative (XI) over Pd/C in MeOH, or by first hydrogenation of (X) over Pd/C in MeOH to give (XII), followed by hydrolysis with KOH in MeOH. On turn, derivative (XII) can alternatively be synthesized by treatment of derivative (VII) with LHMDS, followed by reaction with 3-bromocyclohexene (XIII) in THF to provide derivative (XIV), which is then hydrogenated over Pd/C.

1 Grover, P.T.; et al.; Chiral mandelic acid template provides a highly practical solution for (S)-oxybutynin synthesis. J Org Chem 2000, 65, 19, 6283.
2 Senanayake, C.H.; Bakale, R.P.; Vandenbossche, C.P.; McConville, F.X.; Lopez, J.L. (Sepracor Inc.); Synthesis of optically active cyclohexylphenylglycolic acid and its esters. US 5973182; US 6140529; WO 0023414 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(Ia) 51214 (2R)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid C14H18O3 详情 详情
(Ib),(IV) 51215 (2S)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid C14H18O3 详情 详情
(II) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(III) 51216   n/a C24H31NO6 详情 详情
(V) 12563 (2S)-2-Hydroxy-2-phenylethanoic acid; S-(+)-Mandelic acid 17199-29-0 C8H8O3 详情 详情
(VI) 19797 Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal 630-19-3 C5H10O 详情 详情
(VII) 31681 (2R,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one C13H16O3 详情 详情
(VIII) 11059 Cyclohexanone 108-94-1 C6H10O 详情 详情
(IX) 51217 (2S,5R)-2-(tert-butyl)-5-(1-hydroxycyclohexyl)-5-phenyl-1,3-dioxolan-4-one C19H26O4 详情 详情
(X) 51218 (2S,5S)-2-(tert-butyl)-5-(1-cyclohexen-1-yl)-5-phenyl-1,3-dioxolan-4-one C19H24O3 详情 详情
(XI) 51219 (2S)-2-(1-cyclohexen-1-yl)-2-hydroxy-2-phenylethanoic acid C14H16O3 详情 详情
(XII) 51220 (2S,5S)-2-(tert-butyl)-5-cyclohexyl-5-phenyl-1,3-dioxolan-4-one C19H26O3 详情 详情
(XIII) 30800 3-bromo-1-cyclohexene 1521-51-3 C6H9Br 详情 详情
(XIV) 51221 (2S,5S)-2-(tert-butyl)-5-[(1R)-2-cyclohexen-1-yl]-5-phenyl-1,3-dioxolan-4-one C19H24O3 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Condensation of L-tyrosine methyl ester (I) with 2-benzoylcyclohexanone (II) in the presence of Pd/C in boiling anisole produced the vinylogous amide intermediate (III) which, in the reaction conditions, experienced a dehydrogenation to furnish benzophenone (IV). Then, coupling of (IV) with 2-(5-methyl-2-phenyloxazol-4-yl)ethanol (V) under Mitsunobu conditions afforded ether (VI). Finally, the ester function of (VI) was hydrolyzed with LiOH to give the title acid.

1 Martín, L.; Sorbera, L.A.; Leeson, P.A.; Castañer, J.; Farglitazar. Drugs Fut 2001, 26, 4, 354.
2 N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
3 Willson, T.M.; Mook, R.A. Jr.; Kaldor, I.; Henke, B.R.; Deaton, D.N.; Collins, J.L.; Cobb, J.E.; Brackeen, M.; Sharp, M.J.; O'Callaghan, J.M.; Erickson, G.A.; Boswell, G.E. (Glaxo Wellcome plc); Substd. 4-hydroxy-phenylalkanoic acid derivs. with agonist activity to PPAR-gamma. EP 0888317; JP 2000507216; WO 9731907 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(II) 21432 2-benzoylcyclohexanone 3580-38-9 C13H14O2 详情 详情
(III) 21433 methyl (2S)-2-[(2-benzoyl-1-cyclohexen-1-yl)amino]-3-(4-hydroxyphenyl)propanoate C23H25NO4 详情 详情
(IV) 21434 methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate C23H21NO4 详情 详情
(V) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(VI) 21436 methyl (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoate C35H32N2O5 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

Coupling of N-acetyl-D-thioproline (I) with tyrosine methyl ester (II) using EDC and HOBt yielded dipeptide (III). Subsequent alkylation of the tyrosine phenolic group of (III) with 2,6-dichlorobenzyl bromide (IV) and NaH produced the dichlorobenzyl ether (V). The methyl ester group of (V) was finally hydrolyzed employing LiOH in aqueous THF.

1 Head, J.C.; Warrellow, G.J.; Archibald, S.C. (Celltech Chiroscience plc); Anti-inflammatory tyrosine derivs.. EP 0984981; US 6093696; WO 9854207 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 40791 (4S)-3-acetyl-1,3-thiazolidine-4-carboxylic acid 24877-72-3 C6H9NO3S 详情 详情
(II) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(III) 40792 methyl (2S)-2-([[(4S)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl]amino)-3-(4-hydroxyphenyl)propanoate C16H20N2O5S 详情 详情
(IV) 40793 2-(bromomethyl)-1,3-dichlorobenzene 20443-98-5 C7H5BrCl2 详情 详情
(V) 40794 methyl (2S)-2-([[(4S)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl]amino)-3-[4-[(2,6-dichlorobenzyl)oxy]phenyl]propanoate C23H24Cl2N2O5S 详情 详情

合成路线6

该中间体在本合成路线中的序号:(II)

The borinated tyrosine intermediate (VII) has been obtained as follows: The esterification of L-tyrosine (I) with SOCl2 and methanol gives the methyl ester (II), which is N-protected with Cbz-Cl and K2CO3 to yield the carbamate (III). The O-protection of (III) with benzyl bromide and Cs2CO3 affords the benzyl ether (IV), which is iodinated with I2 and Ag2SO4 to provide the 3-iodotyrosine derivative (V). Finally, the borylation of (V) by means of pinacolatodiborane (VI) catalyzed by PdCl2[bis(diphenylphosphanyl)ferrocene] (PdCl2(dppf)) gives rise to the target tyrosine intermediate (VII).

1 Lin, S.N.; Danishefsky, S.J.; The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: Discovery of a new method to generate cis-propenyl amides. Angew Chem. Int Ed 2002, 41, 3, 512.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48794 (S)-(-)-Tyrosine; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-(-)-Tyrosine; L-3-(4-Hydroxyphenyl)alanine; L-4-Hydroxy-17O-phenylalanine; L-beta-(p-Hydroxyphenyl)alanine; L-Hydroxy Phenyl Alanine; L-tyrosine 60-18-4 C9H11NO3 详情 详情
(II) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(III) 53339 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate n/a C18H19NO5 详情 详情
(IV) 53340 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)phenyl]propanoate n/a C25H25NO5 详情 详情
(V) 53341 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-iodophenyl]propanoate n/a C25H24INO5 详情 详情
(VI) 53342 4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane; Bis(pinacolato)diboron; Diboron pinacol ester 73183-34-3 C12H24B2O4 详情 详情
(VII) 53343 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate n/a C31H36BNO7 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

The 2-aminobenzophenone derivative (III) was prepared by condensation of L-tyrosine methyl ester (I) with 2-benzoylcyclohexanone (II) in refluxing anisole, with concomitant dehydrogenation in the presence of Pd/C. Subsequent Mitsunobu coupling of (III) with 2-(N-Boc-N-methylamino)ethanol (V), prepared from aminoalcohol (IV) and Boc2O, afforded the Boc-protected aminoethyl ether (VI). After removal of the Boc group of (VI) by treatment with trifluoroacetic acid, condensation of the resulting secondary amine (VII) with 2-fluoropyridine (VIII) yielded the 2-aminopyridine derivative (IX). Finally, the methyl ester group of (IX) was hydrolyzed to the title carboxylic acid using LiOH.

1 N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
2 Willson, T.M.; Mook, R.A. Jr.; Kaldor, I.; Henke, B.R.; Deaton, D.N.; Collins, J.L.; Cobb, J.E.; Brackeen, M.; Sharp, M.J.; O'Callaghan, J.M.; Erickson, G.A.; Boswell, G.E. (Glaxo Wellcome plc); Substd. 4-hydroxy-phenylalkanoic acid derivs. with agonist activity to PPAR-gamma. EP 0888317; JP 2000507216; WO 9731907 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
23767 Methoxybenzene; Methyl phenyl ether; Anisole 100-66-3 C7H8O 详情 详情
(I) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(II) 21432 2-benzoylcyclohexanone 3580-38-9 C13H14O2 详情 详情
(III) 21434 methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate C23H21NO4 详情 详情
(IV) 13324 2-Methylaminoethanol; 2-(Methylamino)-1-ethanol 109-83-1 C3H9NO 详情 详情
(V) 34509 tert-butyl 2-hydroxyethyl(methyl)carbamate C8H17NO3 详情 详情
(VI) 34510 methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[(tert-butoxycarbonyl)(methyl)amino]ethoxy]phenyl)propanoate C31H36N2O6 详情 详情
(VII) 34511 methyl (2S)-2-(2-benzoylanilino)-3-[4-[2-(methylamino)ethoxy]phenyl]propanoate C26H28N2O4 详情 详情
(VIII) 34512 2-fluoropyridine 372-48-5 C5H4FN 详情 详情
(IX) 34513 methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl)propanoate C31H31N3O4 详情 详情

合成路线8

该中间体在本合成路线中的序号:(II)

The borinated tyrosine intermediate (VII) has been obtained as follows: The esterification of L-tyrosine (I) with SOCl2 and methanol gives the methyl ester (II), which is N-protected with Cbz-Cl and K2CO3 to yield the carbamate (III). The O-protection of (III) with benzyl bromide and Cs2CO3 affords the benzyl ether (IV), which is iodinated with I2 and Ag2SO4 to provide the 3-iodotyrosine derivative (V). Finally, the borylation of (V) by means of pinacolatodiborane (VI) catalyzed by PdCl2[bis(diphenylphosphanyl)ferrocene] (PdCl2(dppf)) gives rise to the target tyrosine intermediate (VII).

1 Lin, S.N.; Danishefsky, S.J.; The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: Discovery of a new method to generate cis-propenyl amides. Angew Chem. Int Ed 2002, 41, 3, 512.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48794 (S)-(-)-Tyrosine; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-(-)-Tyrosine; L-3-(4-Hydroxyphenyl)alanine; L-4-Hydroxy-17O-phenylalanine; L-beta-(p-Hydroxyphenyl)alanine; L-Hydroxy Phenyl Alanine; L-tyrosine 60-18-4 C9H11NO3 详情 详情
(II) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(III) 53339 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate n/a C18H19NO5 详情 详情
(IV) 53340 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)phenyl]propanoate n/a C25H25NO5 详情 详情
(V) 53341 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-iodophenyl]propanoate n/a C25H24INO5 详情 详情
(VI) 53342 4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane; Bis(pinacolato)diboron; Diboron pinacol ester 73183-34-3 C12H24B2O4 详情 详情
(VII) 53343 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate n/a C31H36BNO7 详情 详情

合成路线9

该中间体在本合成路线中的序号:(I)

Condensation of L-tyrosine methyl ester (I) with 2-benzoylcylohexanone (II) and subsequent dehydrogenation in refluxing anisole in the presence of Pd/C affords the benzophenone derivative (III), which is converted into carboxylic acid (V) by Mitsunobu reaction with heterocyclic alcohol (IV) by means of PPh3 and DEAD in THF followed by saponification of the resulting methyl ester with LiOH in THF/MeOH (1). Coupling of (V) with valinol (VI) by means of HOBt/Et3N and EDC·HCl in CH2Cl2 furnishes amide (VII), which is oxidized by means of 4-methylmorpholine (NMM) and TPAP in CH2Cl2 to furnish aldehyde (VIII). Finally, the desired oxazole is obtained by intramolecular cyclization of (VIII) by means of iodine, PPh3 and Et3N in CH2Cl2.

1 N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
2 Cobb, J.E.; Shearer, B.G.; Lambert, M.H. III; Milburn, M.V. (Glaxo Group Ltd.); Oxazole PPAR antagonists. WO 0117994 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(II) 21432 2-benzoylcyclohexanone 3580-38-9 C13H14O2 详情 详情
(III) 21434 methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate C23H21NO4 详情 详情
(IV) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(V) 48285 (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid C34H30N2O5 详情 详情
(VI) 48289 2-amino-3-methyl-1-butanol; DL-Valinol 473-75-6 C5H13NO 详情 详情
(VII) 48287 (2S)-2-(2-benzoylanilino)-N-[1-(hydroxymethyl)-2-methylpropyl]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanamide C39H41N3O5 详情 详情
(VIII) 48288 (2S)-2-(2-benzoylanilino)-N-(1-formyl-2-methylpropyl)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanamide C39H39N3O5 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

Condensation of L-tyrosine methyl ester (I) with 2-benzoylcylohexanone (II) and subsequent dehydrogenation in refluxing anisole in the presence of Pd/C affords the benzophenone derivative (III), which is converted into carboxylic acid (V) by Mitsunobu reaction with heterocyclic alcohol (IV) by means of PPh3 and DEAD in THF followed by saponification of the resulting methyl ester with LiOH in THF/MeOH (1). Coupling of (V) with acetic acid hydrazide (VI) by means of HOBt/Et3N and EDC.HCl in CH2Cl2 furnishes the diacyl hydrazide (VII), which is finally converted into the desired thiadiazole derivative by treatment with Lawesson's Reagent in refluxing toluene.

1 N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
2 Cobb, J.E.; Shearer, B.G.; Lambert, M.H. III; Milburn, M.V. (Glaxo Group Ltd.); Oxazole PPAR antagonists. WO 0117994 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21431 methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate 1080-06-4 C10H13NO3 详情 详情
(II) 21432 2-benzoylcyclohexanone 3580-38-9 C13H14O2 详情 详情
(III) 21434 methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate C23H21NO4 详情 详情
(IV) 19874 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol C12H13NO2 详情 详情
(V) 48285 (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid C34H30N2O5 详情 详情
(VI) 29262 acetohydrazide 1068-57-1 C2H6N2O 详情 详情
(VII) 48286 (2S)-N'-acetyl-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanohydrazide C36H34N4O5 详情 详情
Extended Information